Repligen Corp.
RGEN
Market Cap$9.56B
Close$
$67.20
60.9% downside
Current Fair Value
60.9% downsideOvervalued by 60.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.56 Billion |
|---|---|
| Enterprise Value | $9.36 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.26 |
| Beta | 1.64 |
| Outstanding Shares | 55,875,894 |
| Avg 30 Day Volume | 514,409 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 643.88 |
|---|---|
| PEG | -694.31 |
| Price to Sales | 17.19 |
| Price to Book Ratio | 4.91 |
| Enterprise Value to Revenue | 15.41 |
| Enterprise Value to EBIT | -1450.37 |
| Enterprise Value to Net Income | 630 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.3 |
Revenue Sources
No data
ESG Score
No data
About Repligen Corp.
CEO: Anthony Hunt